1) to ensure better chance to succeed in the 2nd attempt of the same resolution.

 

2) to avoid embarrassment of the 2nd attempt failure in the " eyes" of the public , as MW proposed resolutions have spread like fire in the market & there is no place to hide their " face" if MW loses again

 

3) to increase their stake by some 10% , ($2 million dollars) more is not very significant which MW can afford it, since MW already holds some 12% of the shares now.

 

4) to ensure better control on the deal of the Acquisition & Fundraising by having a bigger stake in the company & to value add to the deal by renegotiation of the terms and conditions to ensure the valuation is fair and reasonable , eventhough in long term perspective,  the Acquisition of Dental will definitely generate more revenue for the company based on the p/e with target share price of 0.08.

For the approval of  the Acquisition & Fundraising of Asia Dental for the coming special resolution in Dec 21/Jan 22, it needs to garner at least 75% VOTE FOR from the existing shareholders which MW currently holding some $12% of the vote.

CATALIST-LISTED medtech company QT Vascular $ QT Vascular: 5I0 0%is staring down a possible do-over of a recent extraordinary general meeting (EGM), said its board in an update released on Tuesday (Dec 7).

 

The board said it got an e-mail on Monday afternoon from would-be director Christian Kwok-Leun Yau Heilesen, seeking a fresh vote on the resolutions that had failed to pass muster that very morning.

 

Requisitioning shareholders Mission Well Ltd and Tansri Saridju Benui had last month called for an EGM for shareholders to decide on appointing Tansri, Mission Well director Heilesen, and 3 others to the board. The 5 resolutions were rejected at the EGM on Monday.

 

QT Vascular " has been in consultation with its professional advisers to determine the validity of this attempt to convene" a new EGM, the board disclosed. It also said that QT Vascular wants an explanation for the second EGM attempt from Mission Well and Tansri.

 

Besides the nomination of the 5 directors, Mission Well and Tansri also sought the ouster of then-chief executive Eitan Konstantino and 3 others. While Konstantino has since stepped down from his role, there will be another EGM on Dec 15 over the board seats held by executive director Momi Mimon Brosh and independent directors Eric Sho Kian Hin and Ng Boon Eng.

 

The board said in a statement signed by Sho that QT Vascular would keep updating shareholders on material developments " as and when appropriate" , and advised investors to exercise caution when dealing in the securities of the company.

 

QT Vascular called a trading halt on Monday morning " pending the release of announcements" .